Exclusive-Thermo Fisher, Celltrion Vie For Baxter's Biopharma Unit -sources

Exclusive-Thermo Fisher, Celltrion Vie For Baxter’s Biopharma Unit -sources

By Anirban Sen and David Carnevali (Reuters) -U.S. scientific instruments maker Thermo Fisher Scientific Inc and South Korea’s Celltrion Inc are among those competing to acquire the biopharma solutions business of medical device maker Baxter International Inc, according to people familiar with the matter. The divestment, which the sources said could fetch more than $4…

Read More

BlackRock Investment Institute downgrades credit, favors short-term bonds for income

(Reuters) – BlackRock Investment Institute said on Monday it was downgrading credit and preferred short-term bonds for income, with strategists pointing to financial cracks from rapid interest rate hikes. “We stay risk-off: underweight developed market (DM) stocks and trim credit to neutral. But we are ready to seize opportunities as macro damage gets priced in….

Read More